The process which is the breaking down of macromolecules is called Hydrolysis (the breaking of a bond in a molecule using water) This means that polymers are broken down into monomers. This literally means ‘Split water’ and a reaction between an ion and the water molecule is used during used during the breakdown.
The other molecules are triglycerides, low density lipoprotein, and high density lipoprotein.
Answer:
The best example of environmental influence that would most likely result in natural selection is that a food resource disappears in a pond, and some frogs in a population can eat the remaining food resource, while others cannot.
Explanation:
Among the environmental factors that can influence natural selection at a given time is the availability of food. Natural selection, from the point of view of evolution, is influenced by adverse environmental conditions, being food shortage one of them.
In conditions of food shortage in a pond, as in the example of the frog population, only the most apt will be able to take advantage of nutritional resources, while the less apt will not be able to survive. The ability to survive with little food available becomes an inherited trait that will be passed on to future generations.
In any case, tolerance to adverse conditions becomes adaptation, which translates into survival and reproductive success.
- <em>The other options are not correct because </em><u><em>none of them show environmental pressure that can lead to natural selection</em></u><em>.</em>
Answer:
a point in time, event, or experience when one has a sudden insight or realization:
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
